| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |